Bloomberg Law’s combination of innovative analytics, research tools and practical guidance provides you with everything you need to be a successful litigator.
Sept. 21 — Johnson & Johnson must face monetary damages claims in a would-be class suit alleging it deceptively marketed Johnson’s Baby Powder despite a known risk of ovarian cancer ( Mihalich v. Johnson & Johnson , 2016 BL 309923, S.D. Ill., No. 14-00600, 9/20/16 ).
Barbara Mihalich adequately alleged J&J violated the Illinois Consumer Fraud and Deceptive Business Practices Act, the U.S. District Court for the Southern District of Illinois said Sept. 20.
The company failed to warn consumers that use of the powder in the genital area increased a woman’s risk of developing ovarian cancer, she alleged.
Despite the company’s knowledge of talc-related risks, as exhibited by studies dating back many decades, J&J sought to convey an image of a trusted family product, she said.
Had she known about the cancer risk, she would have bought a different product containing cornstarch instead of talc, Mihalich said.
The plaintiff sufficiently alleged that she suffered an economic injury and that J&J was unjustly enriched, the court said.
But the court dismissed claims for requesting an order that would prevent J&J from continuing to market the powder with the alleged misrepresentation and omission of material facts.
Mihalich lacks standing to bring injunctive relief claims, the court said. Mihalich, who now knows about the alleged risk, is unlikely to buy talcum power again and therefore can’t show she faces an immediate threat of future harm.
Goldenberg Heller & Antognoli PC, Blood, Hurst & Reardon LLP and others represent the plaintiffs.
O’Melveny & Myers LLP and Bryan Cave, LLP represent Johnson & Johnson.
To contact the reporter on this story: Julie A. Steinberg in Washington at email@example.com
To contact the editor responsible for this story: Nicholas Datlowe at nDatlowe@bna.com
The opinion is available at http://www.bloomberglaw.com/public/document/Mihalich_v_Johnson__Johnson_No_14cv600DRHSCW_2016_BL_309923_SD_Il.
Copyright © 2016 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)